Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Hims & Hers Health, Inc. (HIMS : NYSE)
 
 • Company Description   
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.

Number of Employees: 2,442

 
 • Price / Volume Information   
Yesterday's Closing Price: $23.75 Daily Weekly Monthly
20 Day Moving Average: 25,086,700 shares
Shares Outstanding: 227.94 (millions)
Market Capitalization: $5,413.55 (millions)
Beta: 2.43
52 Week High: $70.43
52 Week Low: $13.74
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -15.63% -19.75%
12 Week 52.24% 40.74%
Year To Date -26.86% -32.02%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2269 CHESTNUT STREET SUITE 523
-
SAN FRANCISCO,CA 94123
USA		 ph: 415-851-0195
fax: -		 investors@forhims.com http://www.hims.com
 
 • General Corporate Information   
Officers
Andrew Dudum - Chief Executive Officer
Oluyemi Okupe - Chief Financial Officer
Irene Becklund - Chief Accounting Officer
Delos Cosgrove - Director
Anja Manuel - Director

Peer Information
Hims & Hers Health, Inc. (HLIS)
Hims & Hers Health, Inc. (AZTA)
Hims & Hers Health, Inc. (APYI)
Hims & Hers Health, Inc. (RNVA)
Hims & Hers Health, Inc. (HMSY)
Hims & Hers Health, Inc. (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 433000106
SIC: 8011
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 08/03/26
Share - Related Items
Shares Outstanding: 227.94
Most Recent Split Date: (:1)
Beta: 2.43
Market Capitalization: $5,413.55 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.01 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.04 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 12.88% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/03/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 593.75
Trailing 12 Months: 197.92
PEG Ratio: 46.09
Price Ratios
Price/Book: 12.13
Price/Cash Flow: 28.38
Price / Sales: 2.28
EPS Growth
vs. Year Ago Period: -190.00%
vs. Previous Quarter: -357.14%
Sales Growth
vs. Year Ago Period: 3.77%
vs. Previous Quarter: -1.57%
ROE
03/31/26 - 6.10
12/31/25 - 22.48
09/30/25 - 24.67
ROA
03/31/26 - 1.52
12/31/25 - 7.02
09/30/25 - 9.37
Current Ratio
03/31/26 - 1.69
12/31/25 - 1.90
09/30/25 - 1.88
Quick Ratio
03/31/26 - 1.56
12/31/25 - 1.70
09/30/25 - 1.64
Operating Margin
03/31/26 - 1.37
12/31/25 - 5.35
09/30/25 - 6.05
Net Margin
03/31/26 - -0.56
12/31/25 - 5.47
09/30/25 - 6.05
Pre-Tax Margin
03/31/26 - -1.61
12/31/25 - 5.28
09/30/25 - 5.78
Book Value
03/31/26 - 1.96
12/31/25 - 2.38
09/30/25 - 2.55
Inventory Turnover
03/31/26 - 6.59
12/31/25 - 6.08
09/30/25 - 5.69
Debt-to-Equity
03/31/26 - 2.18
12/31/25 - 1.80
09/30/25 - 1.67
Debt-to-Capital
03/31/26 - 68.59
12/31/25 - 64.26
09/30/25 - 62.57
 

Powered by Zacks Investment Research ©